These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26675069)
1. Expression of DNAM-1 (CD226) on inflammatory monocytes. Vo AV; Takenaka E; Shibuya A; Shibuya K Mol Immunol; 2016 Jan; 69():70-6. PubMed ID: 26675069 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD226 is associated to but not required for NK cell education. Wagner AK; Kadri N; Snäll J; Brodin P; Gilfillan S; Colonna M; Bernhardt G; Höglund P; Kärre K; Chambers BJ Nat Commun; 2017 May; 8():15627. PubMed ID: 28561023 [TBL] [Abstract][Full Text] [Related]
4. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383 [TBL] [Abstract][Full Text] [Related]
5. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody. Yamashita Y; Abe F; Hirochika R; Tahara-Hanaoka S; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):60-4. PubMed ID: 23600509 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754 [TBL] [Abstract][Full Text] [Related]
8. DNAM-1 controls NK cell activation via an ITT-like motif. Zhang Z; Wu N; Lu Y; Davidson D; Colonna M; Veillette A J Exp Med; 2015 Nov; 212(12):2165-82. PubMed ID: 26552706 [TBL] [Abstract][Full Text] [Related]
9. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693 [TBL] [Abstract][Full Text] [Related]
11. DNAM-1 expression marks an alternative program of NK cell maturation. Martinet L; Ferrari De Andrade L; Guillerey C; Lee JS; Liu J; Souza-Fonseca-Guimaraes F; Hutchinson DS; Kolesnik TB; Nicholson SE; Huntington ND; Smyth MJ Cell Rep; 2015 Apr; 11(1):85-97. PubMed ID: 25818301 [TBL] [Abstract][Full Text] [Related]
12. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711 [TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1. Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033 [TBL] [Abstract][Full Text] [Related]
17. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. Shibuya A; Lanier LL; Phillips JH J Immunol; 1998 Aug; 161(4):1671-6. PubMed ID: 9712030 [TBL] [Abstract][Full Text] [Related]
19. The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation. Kraus AK; Chen J; Edenhofer I; Ravens I; Gaspert A; Cippà PE; Mueller S; Wuthrich RP; Segerer S; Bernhardt G; Fehr T PLoS One; 2016; 11(2):e0147951. PubMed ID: 26840537 [TBL] [Abstract][Full Text] [Related]